Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safe Return to Play Following ACL Reconstruction: Validation of a Return to Play Checklist

NCT04827264 is registered in ClinicalTrials.gov with Rothman Institute Orthopaedics as lead sponsor.

NCT NCT04827264
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04827264 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safe Return to Play Following ACL Reconstruction: Validation of a Return to Play Checklist
Lead sponsor
Rothman Institute Orthopaedics
Phase
Observational
Overall status
Completed
Start date
February 20, 2016
Completion date
February 20, 2020
Enrollment
222 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acl tear